tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY
US Market
ALNY
Alnylam Pharma
Overview
Analyst Forecasts
AI Stock Analysis
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Alnylam Pharma (ALNY) Stock News & Sentiment

Compare
1,212 Followers
Alnylam Pharma Stock (ALNY) Rockets on FDA Drug Approval
Premium
Market News
Alnylam Pharma Stock (ALNY) Rockets on FDA Drug Approval
4d ago
ALNY
Alnylam Pharma’s Promising Future: Buy Rating Backed by AMVUTTRA’s FDA Approval and Market Leadership Potential
Premium
Ratings
Alnylam Pharma’s Promising Future: Buy Rating Backed by AMVUTTRA’s FDA Approval and Market Leadership Potential
4d ago
ALNY
Alnylam Pharma’s Strategic Advancements and Market Potential Support Buy Rating
Premium
Ratings
Alnylam Pharma’s Strategic Advancements and Market Potential Support Buy Rating
4d ago
ALNY
Alnylam Pharma’s Amvuttra Gains FDA Approval, Positioned as Leading siRNA Treatment for ATTR-CM
Premium
Ratings
Alnylam Pharma’s Amvuttra Gains FDA Approval, Positioned as Leading siRNA Treatment for ATTR-CM
4d ago
ALNY
Positive Outlook for Alnylam Pharma Following FDA Approval of Amvuttra for TTR-CM
Premium
Ratings
Positive Outlook for Alnylam Pharma Following FDA Approval of Amvuttra for TTR-CM
4d ago
ALNY
Alnylam Pharma’s Strategic Positioning and Market Potential Boosted by Early FDA Approval of Amvuttra
Premium
Ratings
Alnylam Pharma’s Strategic Positioning and Market Potential Boosted by Early FDA Approval of Amvuttra
4d ago
ALNY
Cautious Outlook on Alnylam Pharma Amid Amvuttra’s FDA Approval and Pricing Concerns
Premium
Ratings
Cautious Outlook on Alnylam Pharma Amid Amvuttra’s FDA Approval and Pricing Concerns
4d ago
ALNY
More ALNY News >

ALNY News on the Web

Investors should buy Codexis following contract news, says Craig-Hallum
The Fly
Neutral
Alnylam (ALNY) Surges 11.8%: Is This an Indication of Further Gains?
Zacks
Neutral
Stocks Recover Early Losses and Close Higher as Magnificent Seven Stocks Rebound
Barchart
Neutral
Stocks Pare Losses as S&P 500 Looks for Weekly Win
Barchart
Neutral
Alnylam Pharma Stock (ALNY) Rockets on FDA Drug Approval
TipRanks News
Neutral
Stocks Fall on Disappointing Corporate Earnings and Economic Worries
Barchart
Neutral
Stocks making the biggest moves midday: Boeing, Nike, Lockheed Martin, FedEx, Micron Technology and more
CNBC
Neutral
Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy
Zacks
Bullish

News Score - Last 7 Days

Neutral
ALNY
Sector Average
Media Buzz
This Week12 articles
Weekly Average4.25 articles
News Sentiment
This Week100%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ALNY’s Media Buzz Sentiment?
12 articles about ALNY were published this week. In an average week, 4.25 articles are published.
    What is ALNY’s weekly average amount of articles?
    In an average week, 4.25 articles about ALNY are published.
      What is ALNY’s News Sentiment?
      100% of articles about ALNY were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        PLXProtalix
        DVAXDynavax
        OGNOrganon
        IMVTImmunovant
        RBOTVicarious Surgical
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing